Physician profile
Douglas A Ross
NPI 1518161223
$777.58
in general payments reported to CMS, 2019-2025
11 companies · $163 in 2025
The $163 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $225 · 2021: $141 · 2022: $52.69 · 2023: $32.65 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $195.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $529.23 | 2019-2023 | Xarelto |
| Novo Nordisk INC | $83.18 | 2025 | Wegovy |
| Exact Sciences Corporation | $32.92 | 2025 | Cologuard Collection Kit |
| Allergan, INC. | $26.13 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $16.80 | 2020 | |
| Pfizer INC. | $16.80 | 2025 | |
| Abbvie INC. | $15.78 | 2023 | Dalvance |
| Lilly USA, LLC | $15.60 | 2025 | Zepbound, Mounjaro |
| Vital Connect, INC | $14.45 | 2025 | Vitalpatch Rtm |
| Portola Pharmaceuticals, LLC | $13.69 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.